Senti Biosciences Inc (SNTI): Next-Year EPS Estimate 47.57%
As of 2026-03-31, Senti Biosciences Inc (SNTI) has a next-year EPS growth estimate of 47.57%.
On 2026-03-29, analyst consensus for SNTI's next-year EPS growth shifted from 46.79% to 47.57% — a positive change of 0.78 percentage points. The revised estimate has been sustained across 6 subsequent trading sessions.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 47.57%
- EPS growth this year
- N/A
- EPS next quarter (est)
- N/A
- Last price
- $0.77
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-03-31 | 47.57% | N/A | N/A | $0.77 |
| 2026-03-30 | 47.57% | N/A | N/A | $0.79 |
| 2026-03-30 | 47.57% | N/A | N/A | $0.77 |
| 2026-03-30 | 47.57% | N/A | N/A | $0.77 |
| 2026-03-29 | 47.57% | N/A | N/A | $0.79 |
| 2026-03-29 | 47.57% | N/A | N/A | $0.79 |
| 2026-03-27 | 46.79% | N/A | N/A | $0.79 |
| 2026-03-26 | 46.79% | N/A | N/A | $0.88 |
| 2026-03-26 | 46.79% | N/A | N/A | $0.88 |
| 2026-03-26 | 46.79% | N/A | N/A | $0.88 |
| 2026-03-25 | 46.79% | N/A | N/A | $0.88 |
| 2026-03-25 | 46.79% | N/A | N/A | $0.88 |
| 2026-03-25 | 46.79% | N/A | N/A | $0.88 |
| 2026-03-24 | 46.79% | N/A | N/A | $0.86 |
| 2026-03-24 | 46.79% | N/A | N/A | $0.86 |
| 2026-03-24 | 46.79% | N/A | N/A | $0.86 |
| 2026-03-23 | 46.79% | N/A | N/A | $0.90 |
| 2026-03-19 | 46.79% | N/A | N/A | $0.90 |
| 2026-03-18 | 46.79% | N/A | N/A | $0.97 |
| 2026-03-17 | 46.79% | N/A | N/A | $0.98 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Senti Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-03-31, Senti Biosciences Inc (SNTI) has a next-year EPS growth estimate of 47.57%, based on analyst consensus.
When was the latest EPS estimate revision for SNTI?▾
The most recent revision occurred on 2026-03-29, when analysts adjusted the next-year EPS growth estimate from 46.79% to 47.57%.
What sector and industry does Senti Biosciences Inc belong to?▾
Senti Biosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SNTI appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Senti Biosciences Inc (SNTI) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports